Joost Uitdehaag will present during the European Cancer Congress 2013. The poster entitled ‘Drug sensitivity markers for approved kinase inhibitor drugs from cell panel profiling’ decribes the recent results obtained after profiling and bioinformatic analysis of all marketed kinase inhibitor drugs and a wide range of classical chemotherapeutic agents in our cancer cell line panel Oncolines™.
Session title: Translational Research
Track: Translational Research
Abstract number: 665
Date: Saturday, 28 September 2013; 14:30
www.eccamsterdam2013.ecco-org.eu/
